aluates Reports

$ 0.0

Automative

Global Viral and Non-viral Vector Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-33B18628

BUY CHAPTERS

Global Viral and Non-viral Vector Market Research Report 2024

Code: QYRE-Auto-33B18628

Report

December 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AAV

Thermo Fisher Scientific

Oxford BioMedica

Lonza

Genewiz

Revvity

VectorBuilder

OBiO Technology

Takara Bio

Genscript Biotech

GENE Chem

PackGene Biotech

Virovek

Geno Meditech

Viral and Non-viral Vector Market Size

The global market for Viral and Non-viral Vector was valued at US$ 745 million in the year 2023 and is projected to reach a revised size of US$ 1824 million by 2030, growing at a CAGR of 13.2% during the forecast period.

Viral and Non-viral Vector Market

Viral and non-viral vectors are delivery systems used to transfer genetic material into cells for therapeutic or research purposes. Viral vectors are modified viruses engineered to carry and deliver specific genes, taking advantage of their natural ability to infect cells. Common examples include adenoviruses, lentiviruses, and adeno-associated viruses (AAV). Non-viral vectors, on the other hand, are synthetic or naturally derived systems that do not rely on viruses. These include liposomes, nanoparticles, electroporation, and plasmid DNA. While viral vectors offer high efficiency in gene delivery, non-viral vectors are often preferred for their lower immunogenicity, easier production, and enhanced safety profiles.

North American market for Viral and Non-viral Vector is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Viral and Non-viral Vector is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Viral and Non-viral Vector in Pharmaceutical and Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Viral and Non-viral Vector include Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral and Non-viral Vector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-viral Vector.

The Viral and Non-viral Vector market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral and Non-viral Vector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral and Non-viral Vector companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral and Non-viral Vector Market Report

Report Metric	Details
Report Name	Viral and Non-viral Vector Market
Accounted market size in year	US$ 745 million
Forecasted market size in 2030	US$ 1824 million
CAGR	13.2%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	AAV Lentiviruses Retroviruses Adenoviruses DNA Plasmids Others
Segment by Application	Pharmaceutical and Biopharmaceutical Companies Academics and Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, Geno Meditech, PackGene Biotech, VIROVEK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral and Non-viral Vector company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral and Non-viral Vector Market growing?

Ans: The Viral and Non-viral Vector Market witnessing a CAGR of 13.2% during the forecast period 2025-2030.

What is the Viral and Non-viral Vector Market size in 2030?

Ans: The Viral and Non-viral Vector Market size in 2030 will be US$ 1824 million.

Who are the main players in the Viral and Non-viral Vector Market report?

Ans: The main players in the Viral and Non-viral Vector Market are Thermo Fisher Scientific, Oxford BioMedica, Lonza, GENEWIZ, Revvity, VectorBuilder, OBIO Technology, Takara Bio, GenScript Biotech, Gene Chem, Geno Meditech, PackGene Biotech, VIROVEK

What are the Application segmentation covered in the Viral and Non-viral Vector Market report?

Ans: The Applications covered in the Viral and Non-viral Vector Market report are Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others

What are the Type segmentation covered in the Viral and Non-viral Vector Market report?

Ans: The Types covered in the Viral and Non-viral Vector Market report are AAV, Lentiviruses, Retroviruses, Adenoviruses, DNA Plasmids, Others

Recommended Reports

Gene Therapy Market

Viral Vectors Market

Gene Delivery Systems

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral and Non-viral Vector Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 AAV

1.2.3 Lentiviruses

1.2.4 Retroviruses

1.2.5 Adenoviruses

1.2.6 DNA Plasmids

1.2.7 Others

1.3 Market by Application

1.3.1 Global Viral and Non-viral Vector Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical and Biopharmaceutical Companies

1.3.3 Academics and Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral and Non-viral Vector Market Perspective (2019-2030)

2.2 Global Viral and Non-viral Vector Growth Trends by Region

2.2.1 Global Viral and Non-viral Vector Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Viral and Non-viral Vector Historic Market Size by Region (2019-2024)

2.2.3 Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030)

2.3 Viral and Non-viral Vector Market Dynamics

2.3.1 Viral and Non-viral Vector Industry Trends

2.3.2 Viral and Non-viral Vector Market Drivers

2.3.3 Viral and Non-viral Vector Market Challenges

2.3.4 Viral and Non-viral Vector Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral and Non-viral Vector Players by Revenue

3.1.1 Global Top Viral and Non-viral Vector Players by Revenue (2019-2024)

3.1.2 Global Viral and Non-viral Vector Revenue Market Share by Players (2019-2024)

3.2 Global Viral and Non-viral Vector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Viral and Non-viral Vector Revenue

3.4 Global Viral and Non-viral Vector Market Concentration Ratio

3.4.1 Global Viral and Non-viral Vector Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral and Non-viral Vector Revenue in 2023

3.5 Global Key Players of Viral and Non-viral Vector Head office and Area Served

3.6 Global Key Players of Viral and Non-viral Vector, Product and Application

3.7 Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral and Non-viral Vector Breakdown Data by Type

4.1 Global Viral and Non-viral Vector Historic Market Size by Type (2019-2024)

4.2 Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030)

5 Viral and Non-viral Vector Breakdown Data by Application

5.1 Global Viral and Non-viral Vector Historic Market Size by Application (2019-2024)

5.2 Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Viral and Non-viral Vector Market Size (2019-2030)

6.2 North America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Viral and Non-viral Vector Market Size by Country (2019-2024)

6.4 North America Viral and Non-viral Vector Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral and Non-viral Vector Market Size (2019-2030)

7.2 Europe Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Viral and Non-viral Vector Market Size by Country (2019-2024)

7.4 Europe Viral and Non-viral Vector Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral and Non-viral Vector Market Size (2019-2030)

8.2 Asia-Pacific Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024)

8.4 Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral and Non-viral Vector Market Size (2019-2030)

9.2 Latin America Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Viral and Non-viral Vector Market Size by Country (2019-2024)

9.4 Latin America Viral and Non-viral Vector Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral and Non-viral Vector Market Size (2019-2030)

10.2 Middle East & Africa Viral and Non-viral Vector Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024)

10.4 Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Viral and Non-viral Vector Introduction

11.1.4 Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Oxford BioMedica

11.2.1 Oxford BioMedica Company Details

11.2.2 Oxford BioMedica Business Overview

11.2.3 Oxford BioMedica Viral and Non-viral Vector Introduction

11.2.4 Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2019-2024)

11.2.5 Oxford BioMedica Recent Development

11.3 Lonza

11.3.1 Lonza Company Details

11.3.2 Lonza Business Overview

11.3.3 Lonza Viral and Non-viral Vector Introduction

11.3.4 Lonza Revenue in Viral and Non-viral Vector Business (2019-2024)

11.3.5 Lonza Recent Development

11.4 GENEWIZ

11.4.1 GENEWIZ Company Details

11.4.2 GENEWIZ Business Overview

11.4.3 GENEWIZ Viral and Non-viral Vector Introduction

11.4.4 GENEWIZ Revenue in Viral and Non-viral Vector Business (2019-2024)

11.4.5 GENEWIZ Recent Development

11.5 Revvity

11.5.1 Revvity Company Details

11.5.2 Revvity Business Overview

11.5.3 Revvity Viral and Non-viral Vector Introduction

11.5.4 Revvity Revenue in Viral and Non-viral Vector Business (2019-2024)

11.5.5 Revvity Recent Development

11.6 VectorBuilder

11.6.1 VectorBuilder Company Details

11.6.2 VectorBuilder Business Overview

11.6.3 VectorBuilder Viral and Non-viral Vector Introduction

11.6.4 VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024)

11.6.5 VectorBuilder Recent Development

11.7 OBIO Technology

11.7.1 OBIO Technology Company Details

11.7.2 OBIO Technology Business Overview

11.7.3 OBIO Technology Viral and Non-viral Vector Introduction

11.7.4 OBIO Technology Revenue in Viral and Non-viral Vector Business (2019-2024)

11.7.5 OBIO Technology Recent Development

11.8 Takara Bio

11.8.1 Takara Bio Company Details

11.8.2 Takara Bio Business Overview

11.8.3 Takara Bio Viral and Non-viral Vector Introduction

11.8.4 Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024)

11.8.5 Takara Bio Recent Development

11.9 GenScript Biotech

11.9.1 GenScript Biotech Company Details

11.9.2 GenScript Biotech Business Overview

11.9.3 GenScript Biotech Viral and Non-viral Vector Introduction

11.9.4 GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)

11.9.5 GenScript Biotech Recent Development

11.10 Gene Chem

11.10.1 Gene Chem Company Details

11.10.2 Gene Chem Business Overview

11.10.3 Gene Chem Viral and Non-viral Vector Introduction

11.10.4 Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024)

11.10.5 Gene Chem Recent Development

11.11 Geno Meditech

11.11.1 Geno Meditech Company Details

11.11.2 Geno Meditech Business Overview

11.11.3 Geno Meditech Viral and Non-viral Vector Introduction

11.11.4 Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024)

11.11.5 Geno Meditech Recent Development

11.12 PackGene Biotech

11.12.1 PackGene Biotech Company Details

11.12.2 PackGene Biotech Business Overview

11.12.3 PackGene Biotech Viral and Non-viral Vector Introduction

11.12.4 PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024)

11.12.5 PackGene Biotech Recent Development

11.13 VIROVEK

11.13.1 VIROVEK Company Details

11.13.2 VIROVEK Business Overview

11.13.3 VIROVEK Viral and Non-viral Vector Introduction

11.13.4 VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024)

11.13.5 VIROVEK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AAV

Thermo Fisher Scientific

Oxford BioMedica

Lonza

Genewiz

Revvity

VectorBuilder

OBiO Technology

Takara Bio

Genscript Biotech

GENE Chem

PackGene Biotech

Virovek

Geno Meditech

List of Tables

Table 1. Global Viral and Non-viral Vector Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of AAV

Table 3. Key Players of Lentiviruses

Table 4. Key Players of Retroviruses

Table 5. Key Players of Adenoviruses

Table 6. Key Players of DNA Plasmids

Table 7. Key Players of Others

Table 8. Global Viral and Non-viral Vector Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Viral and Non-viral Vector Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Viral and Non-viral Vector Market Share by Region (2019-2024)

Table 12. Global Viral and Non-viral Vector Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Viral and Non-viral Vector Market Share by Region (2025-2030)

Table 14. Viral and Non-viral Vector Market Trends

Table 15. Viral and Non-viral Vector Market Drivers

Table 16. Viral and Non-viral Vector Market Challenges

Table 17. Viral and Non-viral Vector Market Restraints

Table 18. Global Viral and Non-viral Vector Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Viral and Non-viral Vector Market Share by Players (2019-2024)

Table 20. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2023)

Table 21. Ranking of Global Top Viral and Non-viral Vector Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Viral and Non-viral Vector Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Viral and Non-viral Vector, Headquarters and Area Served

Table 24. Global Key Players of Viral and Non-viral Vector, Product and Application

Table 25. Global Key Players of Viral and Non-viral Vector, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Viral and Non-viral Vector Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Viral and Non-viral Vector Revenue Market Share by Type (2019-2024)

Table 29. Global Viral and Non-viral Vector Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Viral and Non-viral Vector Revenue Market Share by Type (2025-2030)

Table 31. Global Viral and Non-viral Vector Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Viral and Non-viral Vector Revenue Market Share by Application (2019-2024)

Table 33. Global Viral and Non-viral Vector Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Viral and Non-viral Vector Revenue Market Share by Application (2025-2030)

Table 35. North America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Viral and Non-viral Vector Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Viral and Non-viral Vector Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Viral and Non-viral Vector Market Size by Country (2025-2030) & (US$ Million)

Table 50. Thermo Fisher Scientific Company Details

Table 51. Thermo Fisher Scientific Business Overview

Table 52. Thermo Fisher Scientific Viral and Non-viral Vector Product

Table 53. Thermo Fisher Scientific Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 54. Thermo Fisher Scientific Recent Development

Table 55. Oxford BioMedica Company Details

Table 56. Oxford BioMedica Business Overview

Table 57. Oxford BioMedica Viral and Non-viral Vector Product

Table 58. Oxford BioMedica Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 59. Oxford BioMedica Recent Development

Table 60. Lonza Company Details

Table 61. Lonza Business Overview

Table 62. Lonza Viral and Non-viral Vector Product

Table 63. Lonza Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 64. Lonza Recent Development

Table 65. GENEWIZ Company Details

Table 66. GENEWIZ Business Overview

Table 67. GENEWIZ Viral and Non-viral Vector Product

Table 68. GENEWIZ Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 69. GENEWIZ Recent Development

Table 70. Revvity Company Details

Table 71. Revvity Business Overview

Table 72. Revvity Viral and Non-viral Vector Product

Table 73. Revvity Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 74. Revvity Recent Development

Table 75. VectorBuilder Company Details

Table 76. VectorBuilder Business Overview

Table 77. VectorBuilder Viral and Non-viral Vector Product

Table 78. VectorBuilder Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 79. VectorBuilder Recent Development

Table 80. OBIO Technology Company Details

Table 81. OBIO Technology Business Overview

Table 82. OBIO Technology Viral and Non-viral Vector Product

Table 83. OBIO Technology Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 84. OBIO Technology Recent Development

Table 85. Takara Bio Company Details

Table 86. Takara Bio Business Overview

Table 87. Takara Bio Viral and Non-viral Vector Product

Table 88. Takara Bio Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 89. Takara Bio Recent Development

Table 90. GenScript Biotech Company Details

Table 91. GenScript Biotech Business Overview

Table 92. GenScript Biotech Viral and Non-viral Vector Product

Table 93. GenScript Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 94. GenScript Biotech Recent Development

Table 95. Gene Chem Company Details

Table 96. Gene Chem Business Overview

Table 97. Gene Chem Viral and Non-viral Vector Product

Table 98. Gene Chem Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 99. Gene Chem Recent Development

Table 100. Geno Meditech Company Details

Table 101. Geno Meditech Business Overview

Table 102. Geno Meditech Viral and Non-viral Vector Product

Table 103. Geno Meditech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 104. Geno Meditech Recent Development

Table 105. PackGene Biotech Company Details

Table 106. PackGene Biotech Business Overview

Table 107. PackGene Biotech Viral and Non-viral Vector Product

Table 108. PackGene Biotech Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 109. PackGene Biotech Recent Development

Table 110. VIROVEK Company Details

Table 111. VIROVEK Business Overview

Table 112. VIROVEK Viral and Non-viral Vector Product

Table 113. VIROVEK Revenue in Viral and Non-viral Vector Business (2019-2024) & (US$ Million)

Table 114. VIROVEK Recent Development

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

Table 118. Authors List of This Report

List of Figures

Figure 1. Viral and Non-viral Vector Picture

Figure 2. Global Viral and Non-viral Vector Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Viral and Non-viral Vector Market Share by Type: 2023 VS 2030

Figure 4. AAV Features

Figure 5. Lentiviruses Features

Figure 6. Retroviruses Features

Figure 7. Adenoviruses Features

Figure 8. DNA Plasmids Features

Figure 9. Others Features

Figure 10. Global Viral and Non-viral Vector Market Size by Application (2024-2030) & (US$ Million)

Figure 11. Global Viral and Non-viral Vector Market Share by Application: 2023 VS 2030

Figure 12. Pharmaceutical and Biopharmaceutical Companies Case Studies

Figure 13. Academics and Research Institutes Case Studies

Figure 14. Others Case Studies

Figure 15. Viral and Non-viral Vector Report Years Considered

Figure 16. Global Viral and Non-viral Vector Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Viral and Non-viral Vector Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Viral and Non-viral Vector Market Share by Region: 2023 VS 2030

Figure 19. Global Viral and Non-viral Vector Market Share by Players in 2023

Figure 20. Global Top Viral and Non-viral Vector Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral and Non-viral Vector as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Viral and Non-viral Vector Revenue in 2023

Figure 22. North America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Viral and Non-viral Vector Market Share by Country (2019-2030)

Figure 24. United States Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Viral and Non-viral Vector Market Share by Country (2019-2030)

Figure 28. Germany Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Viral and Non-viral Vector Market Share by Region (2019-2030)

Figure 36. China Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Viral and Non-viral Vector Market Share by Country (2019-2030)

Figure 44. Mexico Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Viral and Non-viral Vector Market Share by Country (2019-2030)

Figure 48. Turkey Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. UAE Viral and Non-viral Vector Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 52. Oxford BioMedica Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 53. Lonza Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 54. GENEWIZ Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 55. Revvity Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 56. VectorBuilder Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 57. OBIO Technology Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 58. Takara Bio Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 59. GenScript Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 60. Gene Chem Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 61. Geno Meditech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 62. PackGene Biotech Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 63. VIROVEK Revenue Growth Rate in Viral and Non-viral Vector Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Gene Therapy Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global AAV Vector Gene Therapy Market Research Report 2024

Global Viral Vector Manufacturing Market Research Report 2024

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adeno Associated Virus AAV Vector Based Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AAV based Gene Therapy Products Market Research Report 2024

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Gene Delivery Technologies Market Research Report 2024

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global AAV Gene Therapy Drugs Market Research Report 2024

Global AAV Vector Based Gene Therapy Drugs Market Research Report 2024

Lentivirus Particle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions